Paris - Delayed Quote EUR
Valneva SE (VLA.PA)
2.7160
-0.0560
(-2.02%)
At close: June 6 at 5:35:04 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-46,934
-67,218
-202,744
-245,343
76,901
Investing Cash Flow
-10,758
76,916
-20,585
-29,054
-93,117
Financing Cash Flow
32,557
30,682
63,081
215,116
154,504
End Cash Position
151,505
168,271
126,080
286,532
346,642
Capital Expenditure
-13,385
-16,444
-14,312
-29,322
-93,171
Issuance of Capital Stock
--
--
0
189,837
166,823
Issuance of Debt
--
--
81,111
39,331
859
Repayment of Debt
-5,551
-6,487
-5,224
-4,841
-4,761
Repurchase of Capital Stock
--
--
-240
--
--
Free Cash Flow
-60,319
-83,662
-217,056
-274,665
-16,270
12/31/2021 - 6/29/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GNFT.PA Genfit S.A.
3.7220
-3.32%
ABVX.PA ABIVAX Société Anonyme
7.36
+4.99%
ALNFL.PA NFL Biosciences SA
1.1680
0.00%
OSE.PA OSE Immunotherapeutics SA
5.89
-2.64%
NWRN.SW Newron Pharmaceuticals S.p.A.
7.70
+5.19%
NANO.PA Nanobiotix S.A.
4.1550
+2.09%
DBV.PA DBV Technologies S.A.
1.4880
+0.68%
HLOSF Healios K.K.
3.1700
0.00%
4RD.DU Maat Pharma SA
5.24
+4.38%
BIX0.F BioInvent International AB (publ)
3.3800
-0.15%